Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesPreengraftment Syndrome after Unrelated Cord Blood Transplant Is a Strong Predictor of Acute and Chronic Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation, 08/28/09
Frangoul H et al. – The authors conclude that PES is common following CB transplant (CBT) and additional more intensive immune suppression might be considered to decrease the risk of developing aGVHD and cGVHD.
Related Articles
Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft
Transfusion, 10/26/09
Relevance Score: 66%
Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality
Blood, 11/02/09
Relevance Score: 65%
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant
Transfusion, 10/13/09
Relevance Score: 65%
Interleukin 17 Is Not Required for Autoimmune-Mediated Pathologic Damage during Chronic Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation, 10/07/09
Relevance Score: 65%
Oral Chronic Graft-versus-Host Disease Scoring Using the NIH Consensus Criteria
Biology of Blood and Marrow Transplantation, 10/07/09
Relevance Score: 65%
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring
Bone Marrow Transplantation, 12/10/09
A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT
Bone Marrow Transplantation, 12/10/09
Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
Bone Marrow Transplantation, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor